Elizabeth Anne Kolar

This study identifies CB5 (grassofermata) as a potential inhibitor of ACSVL3, showing reduced glioma cell growth and malignancy in vitro and in vivo.

This paper identifies potential inhibitors of ACSVL3, an enzyme overexpressed in glioblastoma, using in vitro assays and a high-throughput screening approach.

This study shows that knocking out ACSVL3 in glioblastoma cells reduces their malignant traits by altering non-lipid metabolic pathways, including glucose and energy metabolism.